Innate Pharma SA 2016 SR
The report outlines Innate Pharma's corporate social responsibility performance for 2016, focusing on its commitment to employees and the local Marseille area. Key highlights include a 31% increase in workforce to support drug research and development, with 65% of staff being women. The company emphasized professional development through new individual tracks and training programs. Environmentally, the company conducted an energy audit to improve the efficiency of its main building and reported on electricity and water consumption. Additionally, Innate Pharma played a significant role in the Marseille-Immunopole ecosystem, fostering innovation and education in immunology.
Company: Innate Pharma SA
Sector: Professional & technical services
Country: France
Year: 2016
Type: SR
Pages: 18
Back to company
Innate Pharma SA
Corporate Social Responsibility Report
The report outlines Innate Pharma's corporate social responsibility performance for 2016, focusing on its commitment to employees and the local Marseille area. Key highlights include a 31% increase in workforce to support drug research and development, with 65% of staff being women. The company emphasized professional development through new individual tracks and training programs. Environmentally, the company conducted an energy audit to improve the efficiency of its main building and reported on electricity and water consumption. Additionally, Innate Pharma played a significant role in the Marseille-Immunopole ecosystem, fostering innovation and education in immunology.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women in Management
Employees